The +252A/G polymorphism in the lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: A meta-analysis

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 4, 2014, Pages 544-552

  Cao, C ^a   Liu, S ^c   Lou, S F ^b   Liu, T ^a  

^a SICHUAN UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c First People's Hospital of Yibin   (China)

Author keywords

Meta analysis; Non Hodgkin lymphoma

Indexed keywords

ARTICLE; CANCER RISK; DNA POLYMORPHISM; ETHNICITY; FOLLICULAR LYMPHOMA; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOTOXIN ALPHA GENE; NONHODGKIN LYMPHOMA; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ETHNOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; META ANALYSIS; RISK; RISK FACTOR;

LYMPHOTOXIN;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; LYMPHOTOXIN-ALPHA; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84896912576     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. SHANKLAND KR, ARMITAGE JO, HANCOCK BW. Non-Hodgkin lymphoma. Lancet 2012; 380: 848-857.
2. SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
3. Cancer Research UK. Non-Hodgkin lymphoma (NHL) statistics-key facts. http://www.cancerresearchuk.org/cancer-info/cancerstats/keyfacts/ nonhodgkin-lymphoma/ (accessed December 15, 2013)
4. SKIBOLA CF, CURRY JD, NIETERS A. Genetic susceptibility to lymphoma. Haematologica 2007; 92: 960-969.
5. SGAMBATO A, CITTADINI A. Inflammation and can cer: a multifaceted link. Eur Rev Med Pharmacol Sci 2010; 14: 263-268.
6. SPINK CF, KEEN LJ, MENSAH FK, LAW GR, BIDWELL JL, MORGAN GJ. Association between non-Hodgkin lymphoma and haplotypes in the TNF region. Br J Haematol 2006; 133: 293-300.
7. DOS SANTOS M, STUR E, MAIA LL, AGOSTINI LP, PETERLE GT, MENDES SO, TAJARA EH, DE CARVALHO MB, LOURO ID, SILVA-CONFORTI AM. Genetic variability of inflammatory genes in the Brazilian population. Genet Test Mol Biomarkers 2013; 17: 844-848.
8. ZHOU P, HUANG W, CHU X, DU LF, LI JP, ZHANG C. The lymphotoxin-α 252A>G polymorphism and breast cancer: a meta-analysis. Asian Pac J Cancer Prev 2012; 13: 1949-1952.
9. WARZOCHA K, RIBEIRO P, RENARD N, BIENVENU J, CHARLOT C, COIFFIER B, SALLES G. Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas. Cancer Immunol Immunother 2000; 49: 469-475.
10. SEIDEMANN K, ZIMMERMANN M, BOOK M, MEYER U, BURKHARDT B, WELTE K, REITER A, STANULLA M. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-551. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of NHL: a meta-analysis Frankfurt-Münster Trial NHL-BFM 95. J Clin Onco 2005; 23: 8414-8421.
11. WANG T, SHEN Y, CHEN L, GUO S, JIA L, YANG T, AN J, WEN F. The-159C/T polymorphism in the CD14 gene and tuberculosis risk: a meta-analysis. Int J Med Sci 2013; 10:1524-1529.
12. SAGOO GS, LITTLE J, HIGGINS JP. Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med 2009; 6: e28.
13. MOHER D, LIBERATI A, TETZLAFF J, ALTMAN DG; PRISMA GROUP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br M J 2009; 339: b2535.
14. AISSANI B, OGWARO KM, SHRESTHA S, TANG J, BREEN EC, WONG HL, JACOBSON LP, RABKIN CS, AMBINDER RF, MARTINEZ-MAZA O, KASLOW RA. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. J Acquir Immune Defic Syndr 2009; 52: 170-179.
15. CERHAN JR, LIU-MARES W, FREDERICKSEN ZS, NOVAK AJ, CUNNINGHAM JM, KAY NE, DOGAN A, LIEBOW M, WANG AH, CALL TG, HABERMANN TM, ANSELL SM, SLAGER SL. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2008; 17: 3161-3169.
16. FITZGIBBON J, GRENZELIAS D, MATTHEWS J, LISTER TA, GUPTA RK. Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br J Haematol 1999; 107: 388-391.
17. HOSGOOD HD 3RD, AU WY, KIM HN, LIU J, HU W, TSE J, SONG B, WONG KF, LEE JJ, CHANOCK SJ, SIU LP, PURDUE MP, SHIN MH, YU J, LIANG R, KIM HJ, ROTHMAN N, LAN Q. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations. Int J Hematol 2013; 97: 793-799.
18. IBRAHIM A, ABDEL RAHMAN H, KHORSHIED M, SAMI R, NASR N, KHORSHID O. Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res 2012; 36: 694-698.
19. LIU J, LIU J, SONG B, WANG T, LIU Y, HAO J, YU J. Genetic variations in CTLA-4, TNF-α, and LTA and susceptibility to T-cell lymphoma in a Chinese population. Cancer Epidemiol 2013; 37: 930-934.
20. NASIRI H, FARAJNIA S, REZAMAND A, MOVASSAGHPOUR AA, ESMAEILI HA, MONFAREDAN A, MOBARRA N, RAHIMIFAR N, SAHEBI L, FARSHDOUSTI HAGH M. Genetic Variations of Tumor Necrosis Factor-α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients. Iran J Basic Med Sci 2013; 16: 990-995.
21. PURDUE MP, LAN Q, KRICKER A, GRULICH AE, VAJDIC CM, TURNER J, WHITBY D, CHANOCK S, ROTHMAN N, ARMSTRONG BK. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 2007; 28: 704-712.
22. ROTHMAN N, SKIBOLA CF, WANG SS, MORGAN G, LAN Q, SMITH MT, SPINELLI JJ, WILLETT E, DE SANJOSE S, COCCO P, BERNDT SI, BRENNAN P, BROOKS-WILSON A, WACHOLDER S, BECKER N, HARTGE P, ZHENG T, ROMAN E, HOLLY EA, BOFFETTA P, ARMSTRONG B, COZEN W, LINET M, BOSCH FX, ENNAS MG, HOLFORD TR, GALLAGHER RP, ROLLINSON S, BRACCI PM, CERHAN JR, WHITBY D, MOORE PS, LEADERER B, LAI A, SPINK C, DAVIS S, BOSCH R, SCARPA A, ZHANG Y, SEVERSON RK, YEAGER M, CHANOCK S, NIETERS A. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006; 7: 27-38.
23. SKIBOLA CF, BRACCI PM, NIETERS A, BROOKS-WILSON A, DE SANJOSÉ S, HUGHES AM, CERHAN JR, SKIBOLA DR, PURDUE M, KANE E, LAN Q, FORETOVA L, SCHENK M, SPINELLI JJ, SLAGER SL, DE ROOS AJ, SMITH MT, ROMAN E, COZEN W, BOFFETTA P, KRICKER A, ZHENG T, LIGHTFOOT T, COCCO P, BENAVENTE Y, ZHANG Y, HARTGE P, LINET MS, BECKER N, BRENNAN P, ZHANG L, ARMSTRONG B, SMITH A, SHIAO R, NOVAK AJ, MAYNADIE M, CHANOCK SJ, STAINES A, HOLFORD TR, HOLLY EA, ROTHMAN N, WANG SS. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 2010; 171: 267-276.
24. WANG SS, CERHAN JR, HARTGE P, DAVIS S, COZEN W, SEVERSON RK, CHATTERJEE N, YEAGER M, CHANOCK SJ, ROTHMAN N. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 2006; 66: 9771-9780.
25. WARZOCHA K, RIBEIRO P, BIENVENU J, ROY P, CHARLOT C, RIGAL D, COIFFIER B, SALLES G. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574-3581.
26. XIAO H, ZHANG K. Genetic polymorphisms of tumor necrosis factor-α and lymphotoxin-α in Chinese patients with non-Hodgkin lymphoma. Ann Hematol 2011; 90: 725-727.
27. YRI OE, EKSTRØM PO, HILDEN V, GAUDERNACK G, LIESTØL K, SMELAND EB, HOLTE H. Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large Bcell lymphoma treated with rituximab. Leuk Lymphoma 2013; 54: 2205-2214.
28. JOST PJ, RULAND J. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 2007; 109: 2700-2707.
29. ZHAO H, ZHONG X, CHEN Y. Relationship of tumor necrosis factor genetic polymorphisms with the clinical course and outcome of Non-Hodgkin's Lymphoma. Chin J Clin Oncol 2010; 37: 23-28.
30. ZHANG Y, CHEN MB, ZHOU XY, HONG XN. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population. PLoS One 2013; 8: e66411.
31. KIDAS E, MÖRICKE A, BEIER R, WELTE K, SCHRAPPE M, STANULLA M, GRIGULL L. Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study. Int J Hematol 2009; 89: 584-591.